A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...
The popularity of GLP-1 weight loss drugs has soared, which had created a shortage among many of the drugs, including Eli ...
Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...
We recently compiled a list of the 8 Best Momentum Stocks To Invest In Right Now. In this article, we are going to take a ...
Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA's drug shortage list, meaning compounders can no longer prepare and dispense the drug.